Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition

Scientists monitored cell viability in organoids, tumor volume, and PSA secretion in patient-derived xenografts and analyzed cell cycle and signaling pathway alterations.